A feasibility study of the transdiagnostic self-injury interview.


Journal

Nordic journal of psychiatry
ISSN: 1502-4725
Titre abrégé: Nord J Psychiatry
Pays: England
ID NLM: 100927567

Informations de publication

Date de publication:
Aug 2023
Historique:
medline: 2 8 2023
pubmed: 30 3 2023
entrez: 29 3 2023
Statut: ppublish

Résumé

The Transdiagnostic Self-injury Interview (TSI) is a new measure that assesses the onset, frequency, methods, and severity of non-suicidal self-injury. The aims were to demonstrate the feasibility of a TSI validation study, and to investigate TSI's criterion validity, clinical correlates, and interrater reliability. Recruiting sites were psychiatric in- and outpatient units. Feasibility targets included number of participants completing the study, TSI completion time, total participation time, participants experiencing exacerbation of symptoms, along with other targets. Criterion validity was evaluated using the Deliberate Self-Harm Inventory (DSHI). Clinical correlates were examined with the Columbia-Suicide Severity Rating Scale (C-SSRS), the Personal and Social Performance Scale, the Affective Lability Scale-18, and the Brief Trauma Questionnaire. Interrater reliability was evaluated with video recordings and written material. Fifty participants were included. The majority were women (76%) and had a mean age of 31.3 years (SD: 10.4). Schizophrenia (44%) and schizoaffective disorder (18%) were the most prevalent diagnoses. TSI took an average 9.3 min to complete and the total participation time was on average less than one hour. One participant experienced an exacerbation of self-injury ideation (without the need of intervention). A significant correlation was found between TSI and DSHI ( The results support the feasibility of a TSI validation study, which is needed to validate TSI in different settings and across diagnoses.

Identifiants

pubmed: 36988197
doi: 10.1080/08039488.2023.2192212
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

581-590

Auteurs

Jesper Nørgaard Kjær (JN)

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Regionspsykiatrien Midt, Viborg, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Tine Holm (T)

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Trine Ellegaard (T)

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Sissel Madsen (S)

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.

Eva Lorentzen (E)

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Ane Bjerg Christensen (AB)

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.

Vibeke Bliksted (V)

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Ole Mors (O)

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Signe Dolmer (S)

Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH